Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Janus Henderson Group plc Insider Profile
4 Followers
Janus Henderson Group plc, Ten Percent Owner at Oruka Therapeutics, holds 2.12M shares in Oruka Therapeutics (Ticker: ORKA). Most recently, Janus Henderson Group plc Bought $5,818 shares of Oruka Therapeutics on Aug 20, 2024 for an estimated value of 17.06K.
Janus Henderson Group plc Oruka Therapeutics (ORKA)Ten Percent Owner
Oruka Therapeutics (ORKA)
Ten Percent Owner
Ranked #55,188 out of 99,635 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-4.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Janus Henderson Group plc's holdings
Insider Roles
Ten Percent Owner
Roles that Janus Henderson Group plc holds in companies
Most Profitable Insider Trade
The most profitable trade made by Janus Henderson Group plc
Janus Henderson Group plc's Trading History
List of latest transactions for each holding click on a transaction to see Janus Henderson Group plc's performance on stock
You May Also Like
Janus Henderson Group plc insider profile FAQ
What is the percentage of profitable transactions made by Janus Henderson Group plc?
The percentage of profitable transactions made by Janus Henderson Group plc is 33%.
What is the average return per transaction made by Janus Henderson Group plc?
The average return per transaction made by Janus Henderson Group plc is -4.60%.
What stocks does Janus Henderson Group plc hold?
Janus Henderson Group plc holds: ORKA stocks.
What was Janus Henderson Group plc’s latest transaction?
Janus Henderson Group plc latest transaction was an Informative Buy of $17.06K.
What was Janus Henderson Group plc's most profitable transaction?
Janus Henderson Group plc’s most profitable transaction was an Informative Buy of ORKA stock on July 26, 2024. The return on the trade was 2.30%.
What is Janus Henderson Group plc's role in Oruka Therapeutics?
Janus Henderson Group plc's role in Oruka Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.